Safeguard Scientific

SFE
Delayed Nyse - 11/18 10:02:00 pm
11.76USD
+0.17%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales - -
EBITDA - -
Operating profit (EBIT) -16,9 -9,92
Pre-Tax Profit (EBT) -15,6 -
Net income -15,6 47,2
P/E ratio -11,3x 5,14x
EPS ( $ ) -0,76 2,29
Dividend per Share (  ) - -
Yield - -
Reference price ( $ ) 8,620 11,760
Announcement Date 02/28/2019
11:00am
-
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 2018 2019 (e)
Debt - -
Finance 0,00 0,00
Operating income (EBITDA) - -
Leverage
(Debt/EBITDA)
- -
Capital Expenditure - -
Free Cash Flow (FCF) - -
Book Value Per Share (BVPS) ( $ ) 3,27 -
Cash Flow per Share (  ) - -
Announcement Date 12/31/1969
07:00pm
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 243 M $ -
Valuation 2019e 2020e
P/E ratio (Price / EPS) 5,14x -8,98x
Capitalization / Revenue - -
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) - -
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   - -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
BNA & Dividende